AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors

St. Jude Children's Research Hospital used AI and genetic data to identify IRS4 as a safer cancer drug target. The breakthrough, published in Science Advances, aims to reduce side effects in solid tumor treatments.